Skip to main content
. 2018 Dec 3;10:1801–1816. doi: 10.2147/CLEP.S175616

Table 2.

Agreement between MoBa and NorPD by trimester, pregestational period, and gestational period

THRT MoBa totala NorPD totala MoBa only NorPD only Both Neither Agreement
n % N % n n n n κb (95% CI) Rangec
6 months prior to LMP 1,001 1.8 1,198 2.1 48 245 953 54,902 0.86 (0.85–0.88) P
First trimester 1,004 1.8 1,129 2.0 111 236 893 54,908 0.83 (0.82–0.85) P
Second trimesterd 1,077 1.9 1,224 2.2 56 203 1,021 54,868 0.89 (0.87–0.90) P
Third trimester 557 1.0 1,165 2.1 64 672 493 54,919 0.57 (0.54–0.59) m
Gestational periode 1,141 2.0 1,325 2.3 21 205 1,120 54,802 0.91 (0.89–0.92) P

Notes:

a

Total study population, n=56,148.

b

Cohen’s kappa coefficient (k).

c

Subdivision of agreement by Landis and Koch: <0, no (no); 0–0.20, slight (s); 0.21–0.40, fair (f); 0.41–0.60, moderate (m); 0.61–0.80, substantial (S); and 0.81–1.00, perfect (P).

d

Weeks 13–16 aggregate the text box “week 13+” from MoBa Q1 and “weeks 13–16” from MoBa Q3.

e

LMP to delivery.

Abbreviations: LMP, last menstrual period; MoBa, Norwegian Mother and Child Cohort Study; MoBa Q1, MoBa questionnaire 1; MoBa Q3, MoBa questionnaire 3; NorPD, Norwegian Prescription Database; THRT, thyroid hormone replacement therapy.